Europe plays R&D catch up
Biomedical research today speaks with an American accent. This is only a recent phenomenon and through concerted efforts in Europe and elsewhere US dominance in life sciences innovation is being challenged.
Prior to 1980, European firms defined the biomedical indus- try, both in terms of market presence and an ability to create and manufacture innovative new products. Underpinned by a chemical industry forged in the crucible of the 19th century industrial revolution, Europe maintained a dominant position in biomedical research for most of the 20th century.